After-Hours Movers: Amazon Sinks on Lower Guidance, Pinterest Up on Beat

Investing.com2022-10-28

After-Hours Stock Movers:

Amazon (AMZN)14% LOWER; reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $127.1 billion versus the consensus estimate of $127.76 billion. Amazon sees Q4 2022 revenue of $140-148 billion, versus the consensus of $155.1 billion.

Edwards Lifesciences (EW)11% LOWER; reported Q3 EPS of $0.61, $0.01 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $1.32 billion versus the consensus estimate of $1.33 billion. Edwards Lifesciences sees FY2022 EPS of $2.40-$2.50, versus the consensus of $2.52.

Pinterest (PINS)10% HIGHER; reported Q3 EPS of $0.11, $0.05 better than the analyst estimate of $0.06. Revenue for the quarter came in at $685 million versus the consensus estimate of $665.54 million.

L3Harris Technologies (LHX)8% LOWER; reported Q3 EPS of $3.26, $0.15 worse than the analyst estimate of $3.41. Revenue for the quarter came in at $4.25 billion versus the consensus estimate of $4.41 billion. L3Harris Technologies sees FY2022 EPS of $12.75-$13.00, versus the consensus of $13.48. L3Harris Technologies sees FY2022 revenue of $16.8 million, versus the consensus of $17.39 million.

DexCom (DXCM)7% HIGHER; reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74 million. DexCom sees Q4 2022 revenue of $2.88-2.91 billion, versus the consensus of $2.89 billion.

Deckers Brands (DECK)6% LOWER; reported Q2 EPS of $3.80, $0.17 better than the analyst estimate of $3.63. Revenue for the quarter came in at $876 million versus the consensus estimate of $804.64 million. Deckers Brands sees FY2023 EPS of $17.50-$18.35, versus the consensus of $18.12.

Vertex Pharma (VRTX)5% HIGHER; reported Q3 EPS of $4.01, $0.39 better than the analyst estimate of $3.62. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.22 billion. Vertex Pharma sees FY2022 revenue of $8.8-8.9 billion, versus the prior of $8.6-$8.8 billion and the consensus of $8.77 billion.

Gilead Sciences (GILD)4% HIGHER; reported Q3 EPS of $1.90, $0.38 better than the analyst estimate of $1.52. Revenue for the quarter came in at $7 billion versus the consensus estimate of $6.13 billion.

Intel (INTC)4% HIGHER; reported Q3 EPS of $0.59, $0.25 better than the analyst estimate of $0.34. Revenue for the quarter came in at $15.3 billion versus the consensus estimate of $15.43 billion. Intel sees Q4 2022 EPS of $0.20, versus the consensus of $0.60. Intel sees Q4 2022 revenue of $14-15 billion, versus the consensus of $16.3 billion

T-Mobile (TMUS)3% HIGHER; reported Q3 EPS of $0.40, $0.01 better than the analyst estimate of $0.39. Revenue for the quarter came in at $19.48 billion versus the consensus estimate of $20.02 billion.

Apple (AAPL)1% LOWER; reported Q4 EPS of $1.29, $0.03 better than the analyst estimate of $1.26. Revenue for the quarter came in at $90.1 billion versus the consensus estimate of $88.76 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
8